Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin.

Houle JM, Strong HA.

Retina. 2002 Dec;22(6):691-7.

PMID:
12476093
[PubMed - indexed for MEDLINE]
2.

Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.

Bessler NM; Vam Study Writing Committee.

Retina. 2004 Aug;24(4):512-20. Erratum in: Retina. 2004 Dec;24(6):990.

PMID:
15300071
[PubMed - indexed for MEDLINE]
3.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

Retina. 2004 Feb;24(1):1-12.

PMID:
15076937
[PubMed - indexed for MEDLINE]
4.

Complications after photodynamic therapy.

Schnurrbusch UE, Jochmann C, Einbock W, Wolf S.

Arch Ophthalmol. 2005 Oct;123(10):1347-50.

PMID:
16219725
[PubMed - indexed for MEDLINE]
5.

Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.

Verteporfin Roundtable Participants.

Retina. 2005 Feb-Mar;25(2):119-34. Review.

PMID:
15689800
[PubMed - indexed for MEDLINE]
6.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.

Kaiser PK; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1132-42. Epub 2006 Mar 15.

PMID:
16538452
[PubMed - indexed for MEDLINE]
7.
8.

Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration.

Schmidt-Erfurth U, Wolf S; PROTECT Study Group.

Br J Ophthalmol. 2008 Dec;92(12):1628-35. doi: 10.1136/bjo.2007.135277. Epub 2008 Sep 4.

PMID:
18772178
[PubMed - indexed for MEDLINE]
9.

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA.

Ophthalmology. 2003 Apr;110(4):667-73.

PMID:
12689884
[PubMed - indexed for MEDLINE]
10.

Back pain after photodynamic therapy with verteporfin.

Pece A, VadalĂ  M, Manzi R, Calori G.

Am J Ophthalmol. 2006 Mar;141(3):593-4.

PMID:
16490525
[PubMed - indexed for MEDLINE]
11.

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

Arch Ophthalmol. 2005 Apr;123(4):448-57.

PMID:
15824216
[PubMed - indexed for MEDLINE]
12.

Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.

Isola V, Pece A, Parodi MB.

Am J Ophthalmol. 2006 Oct;142(4):680-3.

PMID:
17011867
[PubMed - indexed for MEDLINE]
13.

Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.

Sharp DM, Lai S, Markey CM.

Clin Experiment Ophthalmol. 2007 Jan-Feb;35(1):24-31.

PMID:
17300567
[PubMed - indexed for MEDLINE]
14.

Verteporfin infusion-associated pain.

Borodoker N, Spaide RF, Maranan L, Murray J, Freund KB, Slakter JS, Sorenson JA, Yannuzzi LA, Guyer DR, Fisher YL.

Am J Ophthalmol. 2002 Feb;133(2):211-4.

PMID:
11812424
[PubMed - indexed for MEDLINE]
15.

Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.

Aquaron R, Forzano O, Murati JL, Fayet G, Aquaron C, Ridings B.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):925-30. Erratum in: Cell Mol Biol (Noisy-le-grand). 2003 Feb;49(1):123.

PMID:
12699252
[PubMed - indexed for MEDLINE]
16.

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U.

Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.

PMID:
16360209
[PubMed - indexed for MEDLINE]
17.

Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group.

Am J Ophthalmol. 2003 Sep;136(3):407-18.

PMID:
12967792
[PubMed - indexed for MEDLINE]
18.

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U.

Am J Ophthalmol. 2006 Apr;141(4):638-45.

PMID:
16564797
[PubMed - indexed for MEDLINE]
19.

Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration.

Gaynes BI, Fiscella RG.

Expert Opin Drug Saf. 2004 Jul;3(4):345-61. Review.

PMID:
15268651
[PubMed - indexed for MEDLINE]
20.

Verteporfin: new indication. In certain age-related macular degeneration: too little evidence.

[No authors listed]

Prescrire Int. 2004 Feb;13(69):7-9.

PMID:
15055207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk